A polymorphism in the NPPA gene associates with asthma

Clinical and Experimental Allergy

Volumn 38, Issue 7, 2008, Pages 1117-1123

  Lima, J J ^a,b   Mohapatra, S ^b,c   Feng, H ^d   Lockey, R ^b,c   Jena, P K ^c   Castro, M ^b,e   Irvin, C ^b,f   Johnson, J A ^d   Wang, J ^a   Sylvester, J E ^a  

^a NEMOURS CHILDREN S CLINIC   (United States)

^b American Lung Association Asthma Clinical Research Centers   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF VERMONT   (United States)

Author keywords

Asthma; Atrial natriuretic peptide; Genetics; Polymorphisms; Replicate cohort

Indexed keywords

ATRIAL NATRIURETIC FACTOR; NPPA PROTEIN, HUMAN;

ADULT; ARTICLE; ASTHMA; CONTROLLED STUDY; FEMALE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NPPA GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; CASE CONTROL STUDY; COHORT ANALYSIS; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS;

ADULT; ALLELES; ASTHMA; ATRIAL NATRIURETIC FACTOR; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 54449091465     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2008.02955.x     Document Type: Article

References (37)

1. Palmer LJ, Cookson WO. Using single nucleotide polymorphisms as a means to understanding the pathophysiology of asthma. RespirRes 2001; 2:102-12.
2. Cookson WO. Asthma genetics. Chest 2002; 121:7S-13S.
3. Haagerup A, Bjerke T, Schiotz PO, Binderup HG, Dahl R, Kruse TA. Asthma and atopy - a total genome scan for susceptibility genes. Allergy 2002; 57:680-6.
4. Malerba G, Pignatti PF. A review of asthma genetics: gene expression studies and recent candidates. J Appl Genet 2005; 46: 93-104.
5. Park HS, Kim SH, Park CS. The role of novel genes in modifying airway responses in asthma. Curr Allergy Asthma Rep 2006; 6:112-6.
6. Bosse Y, Hudson TJ. Toward a comprehensive set of asthma susceptibility genes. Annu Rev Med 2007; 58:171-84.
7. Holloway JW, Koppelman GH. Identifying novel genes contributing to asthma pathogenesis. Curr Opin Allergy Clin Immunol 2007; 7:69-74.
8. Costello JM, Goodman DM, Green TP. A review of the natriuretic hormone system's diagnostic and therapeutic potential in critically ill children. Pediatr Crit Care Med 2006; 7:308-18.
9. Pandey KN. Internalization and trafficking of guanylyl cyclase/ natriuretic peptide receptor-A. Peptides 2005; 26:985-1000.
10. Vesely DL. Atrial natriuretic peptides in pathophysiological diseases. Cardiovasc Res 2001; 51:647-58.
11. Mohapatra SS, Lockey RF, Vesely DL, Gower WR Jr. Natriuretic peptides and genesis of asthm: an emerging paradigm? J Allergy Clin Immunol 2004; 114:520-6.
12. Sakamoto M, Nakao K, Morii N et al. The lung as a possible target organ for atrial natriuretic polypeptide secreted from the heart. Biochem Biophys Res Commun 1986; 135:515-20.
13. Perreault T, Gutkowska J. Role of atrial natriuretic factor in lung physiology and pathology. Am J Respir Crit Care Med 1995; 151 :226-42.
14. ALA ACRC. The safety of inactivated influenza vaccine in adults and children with asthma. N Engl J Med 2001; 345:1529-36.
15. ALA, ACRC. Clinical trial of low-dose theophylline and monte- lukast in patients with poorly controlled asthma. Am J Respir Crit Care Med 2007; 175:235-42.
16. Lima JJ, Holbrook JT, Wang J et al. The C523A beta2 adrenergic receptor polymorphism associates with markers of asthma severity in African Americans. J Asthma 2006; 43:185-91.
17. Lima JJ, Feng H, Duckworth L et al. Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations. Metabolism 2007; 56:757-65.
18. Kato N, Sugiyama T, Morita H et al. Genetic analysis of the atrial natriuretic peptide gene in essential hypertension. Clin Sci (London) 2000; 98:251-8.
19. Rubattu S, Stanzione R, Di Angelantonio E et al. Atrial natriure- tic peptide gene polymorphisms and risk of ischemic stroke in humans. Stroke 2004; 35:814-8.
20. Rubattu S, Bigatti G, Evangelista A et al. Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. J Am Coll Cardiol 2006; 48:499-505.
21. Nannipieri M, Posadas R, Williams K et al. Association between polymorphisms of the atrial natriuretic peptide gene and protei- nuria: a population-based study. Diabetologia 2003; 46:429-32.
22. Nannipieri M, Manganiello M, Pezzatini A, De Bellis A, Seghieri G, Ferrannini E. Polymorphisms in the hANP (human atrial natriuretic peptide) gene, albuminuria, and hypertension. Hypertension 2001; 37:1416-22.
23. Roussel R, Tregouet DA, Hadjadj S, Jeunemaitre X, Marre M. Investigation of the human ANP gene in type 1 diabetic nephro- pathy: case-control and follow-up studies. Diabetes 2004; 53:1394-8.
24. Guo X, Cheng S, Taylor KD et al. Hypertension genes are genetic markers for insulin sensitivity and resistance. Hypertension 2005; 45:799-803.
25. Halperin E, Eskin E. Haplotype reconstruction from genotype data using imperfect phylogeny. Bioinformatics 2004; 20:1842-9.
26. Balding D, Bishop M. Handbook ofstatistical genetis. Hoboken, NJ: Wiley, 2001.
27. Revicki DA, Leidy NK, Brennan-Diemer F, Sorensen S, Togias A. Integrating patient preferences into health outcomes assessment: the multiattribute Asthma Symptom Utility Index. Chest 1998; 114:998-1007.
28. Hamad AM, Clayton A, Islam B, Knox AJ. Guanylyl cyclases, nitric oxide, natriuretic peptides, and airway smooth muscle function. Am J Physiol Lung Cell Mol Physiol 2003; 285:L973-83.
29. Chanez P, Mann C, Bousquet J et al. Atrial natriuretic factor (ANF) is a potent bronchodilator in asthma. J Allergy Clin Immunol 1990; 86:321-4.
30. Angus RM, McCallum MJ, Hulks G, Thomson NC. Bronchodila- tor, cardiovascular, and cyclic guanylyl monophosphate response to high-dose infused atrial natriuretic peptide in asthma. Am Rev Respir Dis 1993; 147:1122-5.
31. Hulks G, Jardine AG, Connell JM, Thomson NC. Influence of elevated plasma levels of atrial natriuretic factor on bronchial reactivityin asthma. Am Rev Respir Dis 1991; 143:778-82.
32. Hulks G, Thomson NC. High dose inhaled atrial natriuretic peptide is a bronchodilator in asthmatic subjects. Eur Respir J 1994; 7:1593-7.
33. Angus RM, McCallum MJ, Thomson NC. Effect of inhaled atrial natriuretic peptide on methacholine induced bronchoconstriction in asthma. Clin Exp Allergy 1994; 24:784-8.
34. Angus RM, Millar EA, Chalmers GW, Thomson NC. Effect of inhaled atrial natriuretic peptide and a neutral endopeptidase inhibitor on histamine-induced bronchoconstriction. Am J Respir Crit Care Med 1995; 151:2003-5.
35. Kumar M, Behera AK, Lockey RF, Vesely DL, Mohapatra SS. Atrial natriuretic peptide gene transfer by means of intranasal administration attenuates airway reactivity in a mouse model of allergic sensitization. J Allergy Clin Immunol 2002; 110:879-82.
36. Hellermann G, Kong X, Gunnarsdottir J et al. Mechanism of bronchoprotective effects of a novel natriuretic hormone pep- tide. J Allergy Clin Immunol 2004; 113:79-85.
37. Hunter DJ, Kraft P. Drinking from the fire hose - statistical issues in Genomewide Association Studies. N Engl J Med 2007; 357:436-9.